Researchers at UCL have made a significant advance towards developing a treatment for Corneal Surface Disease, using RAFTTM; a UCLB patented technology licensed to Tap Biosystems.

The development was led by Professor Robert Brown at UCL's Tissue Repair and Engineering Centre (TREC) and Professor Julie Daniels at the UCL's Institute of Ophthalmology, in collaboration with TAP Biosystems and funding from the Technology Strategy Board.

Professor Daniels used an innovative method of synthetic tissue production, known...

This page is available to Science|Business Network Members only. If you are already a member then please log in (above).

Note if you are only registered to receive our Bulletin, or have previously purchased an item from our store, this does not give you access to the full benefits of the site. Join Now and plug into the Science|Business Network to get full access to all our news, events and business opportunities.

Science|Business is the first independent media company that brings together researchers, investors and policy makers in the European innovation community. It does so with a top-quality team and unique network of Europe's leading scientific institutions, corporations, policy makers and IP and VC specialists.

Be where innovation begins – become a member. Click here to learn more.